.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
McKesson
Accenture
Farmers Insurance
McKinsey
Queensland Health
Argus Health
Harvard Business School
Merck
Johnson and Johnson

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076225

« Back to Dashboard
NDA 076225 describes ERRIN, which is a drug marketed by Mayne Pharma and is included in one NDA. It is available from two suppliers. Additional details are available on the ERRIN profile page.

The generic ingredient in ERRIN is norethindrone. There are twenty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the norethindrone profile page.

Summary for 076225

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details

Pharmacology for NDA: 076225

Ingredient-typeProgesterone Congeners

Medical Subject Heading (MeSH) Categories for 076225

Suppliers and Packaging for NDA: 076225

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ERRIN
norethindrone
TABLET;ORAL-28 076225 ANDA Teva Pharmaceuticals USA, Inc. 0555-0344 0555-0344-58 6 BLISTER PACK in 1 BOX (0555-0344-58) > 28 TABLET in 1 BLISTER PACK (0555-0344-79)
ERRIN
norethindrone
TABLET;ORAL-28 076225 ANDA Mayne Pharma Inc. 51862-100 51862-100-06 6 BLISTER PACK in 1 CARTON (51862-100-06) > 28 TABLET in 1 BLISTER PACK (51862-100-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.35MG
Approval Date:Oct 21, 2002TE:AB2RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Cipla
Julphar
Teva
Cantor Fitzgerald
Colorcon
Moodys
Fish and Richardson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot